BRACANALYSIS CDX DEVICE
FDA premarket approval P140020/S005 · decided 2016-02-18
Approval details
- PMA number
- P140020
- Supplement
- S005
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- BRACANALYSIS CDX DEVICE
- Generic name
- Cancer-related germline gene mutation detection system
- Applicant
- Myriad Genetic Laboratories
- Date received
- 2015-01-21
- Decision date
- 2016-02-18
- Days to decision
- 393 days
- Decision code
- OK30
- Product code
- PJG
- Advisory committee
- Pathology
- Expedited review
- No
- Location
- Salt Lake Cit, UT
- Statement
- New polymerase to be used in DNA sequencing process.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.